I guarantee you it will be closer to 3.88 than 388. Quit being delusional. This is turning out to be the worst piece of schitt I've ever invested in and I've invested in quite a few. Down again today - down almost every day. Nothing ever changes.
Anavex Life Sciences (AVXL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Soumit Roy from JonesTrading reiterated a Buy rating on the stock and has a $15.00 price target.